AVTX

$21.81+5.55 (+34.13%)

Pre-Market$21.99+0.18 (+0.83%)· Last close May 6

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO